IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,293 | +89.0% | 33,700 | -6.6% | 0.01% | +100.0% |
| Q2 2023 | $684 | -61.1% | 36,100 | -68.2% | 0.00% | 0.0% |
| Q1 2023 | $1,758 | +175.1% | 113,400 | +215.0% | 0.00% | 0.0% |
| Q4 2022 | $639 | -99.6% | 36,000 | +32.8% | 0.00% | +200.0% |
| Q3 2022 | $151,000 | +43.8% | 27,100 | 0.0% | 0.00% | – |
| Q2 2022 | $105,000 | -29.5% | 27,100 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $149,000 | -35.2% | 27,100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $230,000 | +223.9% | 27,100 | +230.5% | 0.00% | – |
| Q3 2021 | $71,000 | -83.1% | 8,200 | -9.9% | 0.00% | -100.0% |
| Q4 2020 | $420,000 | +37.3% | 9,100 | +4.6% | 0.00% | +100.0% |
| Q3 2020 | $306,000 | +157.1% | 8,700 | +77.6% | 0.00% | 0.0% |
| Q2 2020 | $119,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |